Objective: Nicorandil, a K-ATP channel opener with a nitrate-like effect, is a potent vasodilator and has favorable hemodynamic effects in heart failure patients. While its cardio-protective properties in the setting of acute ischemia are well known, the long-term effects of oral nicorandil therapy on post-infarction left ventricular (LV) dilatation have not been investigated. Methods: Myocardial infarction (MI) was induced in 30 Sprague-Dawley rats by 1 h of coronary artery occlusion followed by reperfusion. After matching for infarction size, animals were randomly assigned to nicorandil treatment (3 mg / kg / day) given in tap water or no treatment (control group). Treatment was started 2 days after MI and continued for 8 weeks. Contrast-enhanced and functional magnetic resonance imaging (MRI) were used to determine infarction size, LV volumes, mass, ejection fraction, and regional wall thickness. Results: Nicorandil significantly decreased end-systolic volumes (0.3360.02 ml; P,0.05) and improved LV ejection fraction (3762%; P,0.01) compared to control rats (0.4360.04 ml and 2862%, respectively) 8 weeks after MI. During the study period, the increase in LV mass (DLVM) was significantly greater in control (0.0960.03 g) than in treated animals (0.0260.02 g, P,0.05). Moreover, nicorandil improved systolic wall thickening of the rim of infarction (P,0.001) and remote non-infarcted regions (P,0.01). Conclusion: These results demonstrate that the long-term oral treatment with nicorandil started 2 days after MI attenuates left ventricular dilatation and improves cardiac function in rats with reperfused MI.
Introduction
mate goal for medical therapy. A powerful therapeutic approach in attenuating LV remodeling is inhibition of the The underlying mechanism leading to heart failure after renin-angiotensin system. Angiotensin-converting enzyme myocardial infarction (MI) is represented by left ventricu-(ACE) inhibitors have been shown to favorably influence lar (LV) remodeling, a process that is characterized by parameters of LV remodeling and thereby improve sympprogressive LV dilatation and impairment of function.
toms and survival in patients with post-infarction heart Remodeling is a time-dependent process involving both failure [5, 6] . Their efficacy has been at least partly infarcted and non-infarcted myocardium [1, 2] . It is mainly attributed to their effects on cardiovascular hemodynamics determined by the size [3] , transmurality and location of resulting in a reduction of pre-and afterload. MI as well as the patency of the infarct-related artery [4] .
Nicorandil, an adenosine triphosphate (ATP) sensitive 1 Slowing or reversing the remodeling process is the ultipotassium (K ) channel opener with a nitrate-like effect, is clinically approved as an anti-anginal drug in Japan and Europe [7] . Nicorandil is a potent vasodilator that acts on dynamic studies in animals [8] and humans [9, 10] demonstrated that nicorandil has similar hemodynamic intravenously via the tail vein. Gd-mesoporphyrin (Scherproperties as ACE-inhibitors, such as decreasing LV ending AG, Berlin, Germany) is a gadolinium-porphyrin diastolic pressure and peripheral vascular resistance. Thus, chelate that has high affinity for necrotic myocardium [18] . this pharmacologic profile would predictably be of benefit Gd-mesoporphyrin produces persistent enhancement in in post-infarction LV dilatation.
necrotic tissue up to 24 h after injection that matches While the beneficial effects of nicorandil in the setting precisely true infarction size on autopsy. The detailed of acute ischemia, such as reduction of infarction size physiochemical properties of Gd-mesoporphyrin have been [11, 12] and preservation of microvascular integrity previously described [19] . Gd-mesoporphyrin contrast-en- [13, 14] , are well documented, the effects of nicorandil on hanced MRI was used to determine infarction size in the post-infarction LV dilatation have not been tested. Thereacute phase. For the assessment of LV volumes and fore, the purpose of this study was: (1) to investigate the function 8 weeks after MI, unenhanced MRI images were long-term effects of oral nicorandil therapy on LV volumes acquired. and function in rats with 2-day-old infarction; and (2) to Both MRI sessions (2 days and 8 weeks after MI) were show the potential of MRI to noninvasively monitor the conducted with a 2.0 T magnet (Omega CSI, Bruker changes in LV volumes, mass, and wall thickness in rats Instruments, Fremont, CA). Each animal was placed in a subjected to reperfused MI. The effects of therapy were supine position in a home-built birdcage resonator and was determined in animals with identical infarction sizes using connected to an ECG monitor (AccuSync 6L, AMR a new necrosis-specific MR contrast medium.
Corporation, Milford, CT) that provided a trigger signal at the R wave for ECG gating and heart rate monitoring. Multi-slice short-axis images were acquired encompassing 2. Methods the entire heart at end-diastole and end-systole using T1-weighted spin-echo imaging. Acquisition parameters were 2.1. Animal preparation TR5450-600 ms; TE512 ms; slice thickness52 mm; number of acquisitions per step54; field of view550350 All experimental procedures received previous approval mm; raw data matrix52563128 zero-filled to 2563256; from the Committee on Animal Research at our institution and voxel dimensions50.0430.0432 mm. End-diastolic and were performed in accordance with the Guide for the images were acquired at the origin of R wave and endCare and Use of Laboratory Animals published by the US systolic images at 45% of the RR-interval [12, 18] . National Institutes of Health [15] . Sprague-Dawley rats (Simonsen Labs, Gilroy, CA) were housed in an air-2.3. Experimental protocol conditioned room with a 12-h light / dark cycle; they received a standard laboratory rat chow and tap water (with Rats with identical infarction size were used in the or without nicorandil). Prior to surgery and MRI sessions, current study to eliminate the effect of infarction size on rats were anesthetized with a mixture of ketamine (90 the magnitude of LV dilatation at 8 weeks. After the mg / kg) and xylazine (4.0 mg / kg) administered intrapericompletion of the first MRI, infarction size (% of total LV) toneally. They were intubated and mechanically ventilated was determined on contrast-enhanced images and rats were with room air using a small animal ventilator (Harvard divided into two groups; namely control (n515) and rodent respirator, Harvard Apparatus, South Natick, MA).
nicorandil-treated group (n515). Treated animals received In the current study, an established rat model of 3 mg / kg / day nicorandil (Chugai Pharmaceutical Co. Ltd., coronary occlusion / reperfusion was used to produce LV Tokyo, Japan) dissolved in tap water, while control dilatation [16, 17] . Experimental MI was induced by temanimals received tap water solely. A fresh solution was porary ligation of the left anterior descending (LAD) prepared every 2 days. The average volume of solution artery. The LAD was occluded for 1 h by placing a snare ingested was 10 ml / 100 g body weight / day (¯3 mg / kg / loop around the vessel. Coronary ligation was considered day), which was in agreement with our prior experiments successful when the anterior LV wall turned pale. After 1 h in rats [20] . the snare loop was released but kept in place for later postmortem measurement of the area at risk. Reperfusion 2.4. Postmortem evaluation was confirmed by a myocardial blush over the ischemic pale zone after the release of the snare. Thereafter, the After completion of the second MRI (8 weeks after MI) chest was closed in layers and the air was evacuated from the LAD was re-occluded using the snare loop left in place the thoracic cavity.
at the initial operation and 0.2 ml phthalocyanine blue dye (Engelhard Corp., Louisville, KY) was injected into the 2.2. MR imaging tail vein. The dye imparts a blue color to normally perfused myocardium, but the territory supplied by the Twelve hours prior to the first MRI session (2 days after occluded artery remains unstained representing the area at MI) all animals received 0.05 mmol / kg Gd-mesoporphyrin risk. Animals were sacrificed thereafter by intravenous injection of saturated KCl solution. The heart was excised between LV mass measured at autopsy and with MRI. and the LV was weighed after removal of the atria and the Differences were considered significant at P,0.05. right ventricle. The LV was transversely sliced into 2-mmthick slices corresponding to the MR images. Both upper and lower surfaces of the stained slices were scanned with 3. Results a flatbed scanner (Silverscan IV, LaCie Limited, Hillsboro, OR). Each slice was then incubated in 2% of triphenyltetAll infarcted regions were located in the antero-lateral razolium chloride (TTC) solution (Sigma Chemical Co., wall of the LV. The reperfused MI was visualized as a St. Louis, MO) to define infarcted myocardium. Subbright region on T1-weighted spin-echo images 12 h after sequently, wet tissue samples were weighed, dried in a the administration of Gd-mesoporphyrin (Fig. 1 ). Prior to vacuum oven for 7 days, and re-weighed to calculate wet treatment animals were divided into two groups based on weight / dry weight ratio.
the size of MI. Therefore, infarction size was identical in control (3662% of total LV) and in nicorandil-treated rats 2.5. Data analysis (3662%).
All images were transferred via Ethernet to a computer 3.1. LV volumes and mass (Macintosh G3, Apple Computers, Cupertino, CA) and analyzed using the NIH Image software tool (NIH Image At 2 days after MI, there were no significant differences version 1.59, Bethesda, MD). By delineating endo-and in LV volumes and mass between control and nicorandilepicardial contours on end-diastolic and end-systolic imtreated animals (Table 1) . At 8 weeks after MI, endages and adding them together, LV volumes and mass were systolic volumes (ESV) were significantly smaller in determined as previously described [21] . The LV mass was nicorandil-treated (0.3360.02 ml) compared to control rats calculated as the sum of myocardial volume multiplied by (0.4360.04 ml; P,0.05). End-diastolic volumes (EDV) the density of myocardial tissue (1.05 mg / ml).
did not differ between both groups, although there was a The Gd-mesoporphyrin enhanced zone was delineated trend towards smaller volumes in the treated group (P5 on end-diastolic images to determine the size of MI in the 0.12). Long-term oral nicorandil therapy significantly acute phase. The extent of the infarcted region defined by improved LV ejection fraction (EF) compared to control MRI as a percentage of the total LV was calculated as the animals (3762% vs. 2862%; P,0.01). Representative sum of Gd-mesoporphyrin enhanced regions for all slices MR images obtained 8 weeks after MI clearly demonstrate divided by the sum of LV cross-sectional areas from all the smaller LV chamber dimensions in treated animals slices. (Fig. 2) . On day 2 after infarction, absolute wall thickness and MI resulted in a significant increase in EDV and ESV systolic wall thickening were measured on three contiguaccompanied by a decline in EF in both groups. However, ous mid-ventricular slices in the mesoporphyrin enhanced the observed changes were less pronounced in the treated zone, the rim of the infarcted zone and in remote nongroup. Additionally, stroke volume (SV) increased siginfarcted myocardium. Eight weeks after infarction, wall nificantly in nicorandil-treated animals, but not in control thickness was used to define infarction, rim of infarction rats (Table 1) . and remote non-infarcted myocardium. Furthermore, unenAt day 2 after MI, LV mass (LVM) was similar in both hanced MR images were visually aligned with stained groups. After 8 weeks, the absolute change in LVM was postmortem LV sections according to anatomical landsignificantly greater in control animals (DLVM 0.0960.03 marks (i.e. papillary muscles, insertion of the right ventrig) than that in treated rats (0. (Fig. 3) . Wet weight / dry weight ratios were the groups were compared by applying the paired t-test for similar in both groups (4.660.1 in control vs. 4.760.1 in normally distributed variables and the Wilcoxon signedtreated rats; P5NS), suggesting that the increase in LVM rank test for nonparametric data. Differences in absolute in control rats was not related to myocardial edema. wall thickness and wall thickening between three different myocardial regions were assessed with analysis of variance 3.2. Absolute wall thickness and systolic wall thickening followed by the Student-Newman-Keuls post-hoc method. Linear regression was used to determine the correlation
The absolute values for wall thickness and wall thicken- ing are presented in Table 2 . At day 2 after MI, wall infarcted myocardium increased significantly in control thickness as well as systolic wall thickening were similar rats (1.8860.05 mm to 2.0260.03 mm; P,0.05), while in both groups. Compared to remote non-infarcted myocarlittle change was observed in nicorandil-treated animals dium wall thickening was markedly reduced in infarcted (1.8660.05 mm to 1.8760.02 mm; P5NS). Moreover, and rim regions (P,0.05).
nicorandil therapy improved systolic wall thickening in rim After 8 weeks, diastolic wall thickness of remote nonof infarction (P,0.001) and remote non-infarcted myocardium (P,0.01) (Fig. 4) . Compared to remote areas wall thinning and persistent regional dysfunction were observed ischemia. Animal [12, 22] and human [13, 14] studies have demonstrated that nicorandil reduces infarction size and cologic preconditioning [24] ; (4) prevention of Ca improves the recovery of postischemic contractile dysfuncoverload by opening K channels [25] ; and (5) free ATP tion, when administered intravenously during occlusion or radical scavenger and neutrophil-modulating properties reperfusion. Several mechanisms were proposed to be [22, 26] . responsible for these cardioprotective effects of nicorandil While the mechanisms of nicorandil to protect myocarincluding: (1) reduction in pre-and afterload [9] ; (2) dium during acute ischemic injury are well-documented, improvement of myocardial perfusion [9, 23] ; (3) pharmalittle is known about its effects in infarction-induced LV Fig. 4 . Bar graph showing regional wall thickening 8 weeks after MI in control and nicorandil-treated animals. Systolic wall thickening in rim and remote non-infarcted myocardium is substantially improved in treated compared to control rats. *P,0.05 compared to the acute phase.
rected to the pharmacologic attenuation of LV dilatation after acute myocardial infarction. Several clinical trials have shown that ACE-inhibitors [5, 6] and more recently b-blocking agents [31] are effective in slowing or reversdilatation. Hemodynamic measurements in healthy voling the deleterious process of LV remodeling. In this unteers [9] and patients with impaired ejection fraction animal model of 8-weeks old infarction, we observed that [10, 27] demonstrated that nicorandil decreases peripheral nicorandil exerted similar effects by reducing LV-ESV and vascular resistance and LV end-diastolic pressure, but preserving LV function. These preliminary results demonincreases stroke volume and myocardial perfusion. These strate for the first time that LV dilatation can be slowed and effects were ascribed to a coronary vasodilating effect may be prevented by oral nicorandil therapy started 2 days combined with a balanced peripheral action on veins and after infarction. Longer term studies in larger animals are arteries, which leads to decreases in both pre-and afterneeded to address the issue of whether nicorandil delays or load, respectively. Although the mechanism of action of prevents LV dilatation. nicorandil was not the scope of this investigation, it is During the study period diastolic wall thickness of conceivable that this hemodynamic profile may be the remote non-infarcted myocardium increased significantly cause of protection found in the current study.
in control animals, while nicorandil therapy attenuated the Clinical parameters currently used to determine the hypertrophic response in these regions. Several cellular magnitude of the structural and functional changes after mechanisms, such as activation of the mitogen-activated MI include the measurement of LV volumes, mass, and protein kinase (MAPK) cascades (extracellular signal-regfunction [28] . It has been demonstrated that the extent of ulated protein kinase, p38-MAPK and c-Jun N-terminal 21 these changes is associated with short-and long-term kinase) and / or involvement of pathways modifying Ca prognosis in patients with infarction-induced heart failure.
handling, have been proposed as possible transduction Particularly, LV-ESV [29] and EF [30] have been reported mechanisms between hypertrophic stimuli and protein to be major determinants of survival in the post-MI synthesis [32] . It may be possible that nicorandil has a population. Therefore, increasing efforts have been didirect molecular effect in this regard by preventing in- Table 2 Absolute wall thickness and systolic wall thickening in infarcted, rim and remote myocardium 21 tracellular Ca loading [25] or by interfering with one of of the heart. It has also been shown that the magnitude of the signal transduction pathways. Further research should the nicorandil effect (i.e. reduction of infarction size) is address these points.
positively correlated with the applied dosage and the plasma concentration of the drug [44] .
Noninvasive assessment with MRI
Thirdly, it must be recognized that any animal model may not fully represent the complex clinical situation in Several imaging modalities, such as echocardiography, patients. Moreover, it remains to be shown whether the radionuclide imaging, and computed tomography have observed effect of nicorandil will be additive to the been used to determine cardiac morphology and function.
salutary effects of ACE-inhibition and b-blockade in the However, for repeated measurements a highly accurate and setting of LV remodeling. Therefore, more studies with reproducible single imaging technique is mandatory. Carlonger treatment periods are warranted to prove whether diac MRI allows reliable quantification of volumes and nicorandil has any effect on morbidity and mortality in function in the morphologically abnormal LV with high experimental and clinical heart failure. Further research is reproducibility and low interstudy variability [21] . Comawaited to address these very important points. pared with echocardiography [33] , MRI does not rely on assumptions about chamber shape and geometry which is of particular importance in hearts deformed by asymmetric 5. Conclusion dilation. Thus, cardiac MRI is ideally suited to assess LV volumes and function after MI and to document the Our results indicate that oral long-term treatment with response to therapies [34] [35] [36] .
nicorandil started 2 days after infarction attenuates LV Animal [37] and human studies [3, 38] have indicated dilatation in a rat model of reperfused MI. Cardiac MRI is that infarction size is one of the major determinants of LV a valuable noninvasive method to study the structural and remodeling. Non-specific standard extracellular MR confunctional changes after acute MI and to monitor the trast media have been employed extensively for sizing and effects of new therapies designed to reduce LV dilatation. characterizing myocardial injuries [39, 40] . More recently, several reports [17] [18] [19] 41, 42] have indicated that necrosisspecific MR contrast media, represented by Gd-mesoporphyrin, provide a more accurate measurement of acute MI.
Secondly, the plasma and tissue levels of nicorandil dium after oral administration has been previously ad- [7] Roland E. Safety profile of an anti-anginal agent with potassium dressed [43] . Sakai et al. [43] found that nicorandil given channel opening activity: an overview. Eur Heart J 1993;14(Suppl orally to rats is preferentially distributed into mitochondria B):48-52.
